The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

Vertex is also testing the drug as a treatment ... The drug also appears to have far milder side effects than opioids. Its efficacy, however, may leave something to be desired.

Vertex Pharma's non-opioid painkiller suzetrigine ... forward in the bid to find effective pain relief free of the side effects and risk of dependency that accompanies the use of opioids.

Pain relief typically kicked in within two to four hours, according to Vertex, and VX-540 was also associated with manageable side effects, mainly minor complaints like nausea, headache ...

Vertex Pharmaceuticals Inc. (NASDAQ ... All this is done without addictive effects, contrary to opioids. 2-Efficacy & Safety Clinical trials in abdominoplasty and bunionectomy patients showed ...

The Nasdaq Composite Index ( ^IXIC -4.00%) is now squarely in correction territory. But stock market corrections have one key ...

Vertex Pharmaceuticals generated more than $ ... Today's over-the-counter choices sometimes aren't effective and even come with side effects -- such as liver toxicity in the case of acetaminophen.